Champions Oncology Inc., of Hackensack, N.J., added Dan Mendelson and Arthur G...DelMar Pharmaceuticals, of Vancouver, British Columbia, added John K. Bell to its board

Xenon Pharmaceuticals Inc., of Vancouver, British Columbia, named Gary J. Bridger executive vice president, research and development

Anavex Life Sciences Corp., of Vancouver, British Columbia, named Athanasios (Tom) Skarpelos a director of the company...Rexahn Pharmaceuticals Inc., of Rockville, Md., named Peter D. Suzdak CEO and Chang AHN chief scientist

Sirona Biochem Corp., of Vancouver, British Columbia, appointed Neil Belenkie CEO...Zyngenia Inc., of Gaithersburg, Md., added Christian Itin and Jason Rhodes to its board

Cardiome Pharma Corp., of Vancouver, British Columbia, appointed Jennifer Archibald chief financial officer...SpringLeaf Therapeutics Inc., of Boston, appointed Pieter Muntendam president and CEO

Anavex Life Sciences Corp., of Vancouver, British Columbia, named Robert Chisholm chief financial officer...Saladax Biomedical Inc., of Bethlehem, Pa., named Kevin Harter president and CEO

Northwest Biotherapeutics, of Bethesda, Md., added Navid Malik and Jerry Jasinowski to its board...QLT Inc., of Vancouver, British Columbia, appointed Christopher Muller chief commercial officer

and Christine Mikail, executive vice president, corporate development, general counsel and secretary...Sirona Biochem, of Vancouver, British Columbia, appointed Brett Premack scientific consultant

Sirona Biochem Corp., of Vancouver, British Columbia, appointed Pierre Vogel, Bernard Langlois and Eric Leclerc to the scientific advisory board of its subsidiary TFChem...Zymeworks Inc., of Vancouver, British Columbia, appointed Gordon Ng vice president of preclinical R&D and added Tom Boone to its strategic therapeutics initiative

Pacgen Biopharmaceuticals Corp., of Vancouver, British Columbia, named Ming S. Liu CEO and director

EnGene Inc., of Vancouver, British Columbia, appointed Richard M. Glickman to its board...Scott L. Friedman and Maria Isabel Fiel were named as consultants

Silence Therapeutics plc, of London, appointed Thomas Christely CEO and named Tony Sedgwick chief business officer...Sirona Biochem Corp., of Vancouver, British Columbia, appointed Jocelyne Logoedec lead project biologist at French subsidiary TFChem

Ablexis LLC, of San Francisco, appointed Jake Bauer senior director of corporate development and business operations...Allon Therapeutics Inc., of Vancouver, British Columbia, appointed Michael Aldridge to its board

PolyTherics Ltd., of London, named John Burt CEO and board member after Keith Powell stepped down...RepliCel Life Sciences, of Vancouver, British Columbia, appointed Peter Lewis to its board

Proteostasis Therapeutics Inc., of Cambridge, Mass., named Alfred Goldberg and Daniel Finley scientific co-founders...Sirona Biochem Corp., of Vancouver, British Columbia, appointed Stuart Maddin to its scientific advisory board

Protox Therapeutics Inc., of Vancouver, British Columbia, named William Rohn and Arnit Sobti to its board

Allon Therapeutics Inc., of Vancouver, British Columbia, appointed Michael Gold vice president of clinical development and chief medical officer

and Manuela Maronati vice president, sales and marketing, Europe...Sirona Biochem Corp., of Vancouver, British Columbia, appointed Frank Palmer advisor

Sirona Biochem Corp., of Vancouver, British Columbia, appointed Michael Rogers to its board...Topaz Pharmaceuticals Inc., of Horsham, Pa., appointed Bob Radie president and CEO